ACP Tablets 25 mg

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Buy It Now

Active ingredient:

Acepromazine

Available from:

Novartis Animal Health UK Ltd

ATC code:

QN05AA04

INN (International Name):

Acepromazine

Authorization status:

Expired

Summary of Product characteristics

                                Revised: 27 June 2008
AN: 01920/2007
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
ACP Tablets 25 mg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance:
mg/tablet
Acepromazine
25.0
(as Acepromazine maleate
33.85)
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
Pale yellow biconvex tablets, approximately 8 mm in diameter, scored
on one side only.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dog and cat.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
_Anaesthetic premedication:_ Following acepromazine administration,
the amount of
anaesthetic dose necessary to induce anaesthesia is considerably
reduced. This reduction
is approximately one-third of a suitable induction agent.
_Tranquillisation:_ Acepromazine tranquillisation (ataraxy) involves a
modification of
temperament which is not associated with hypnosis, narcosis, or marked
sedation. This is
achieved with low doses of acepromazine.
_Sedation:_ At higher dose rates acepromazine is a sedative.
_Travel Sickness:_ A dose of 1 mg per kg given orally a quarter to
half an hour before a light
meal is effective in the prevention of travel sickness. Idiopathic
vomiting may be
controlled by acepromazine.
4.3
CONTRAINDICATIONS
Do not use in pregnant animals (see section 4.7).
Do not use on a long term basis in individual animals.
Revised: 27 June 2008
AN: 01920/2007
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
There are no known additional special warnings.
4.5
SPECIAL PRECAUTIONS FOR USE
I)
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Acepromazine is hypotensive. Particular care should therefore be taken
in hypovolaemic
subjects; rehydration should precede acepromazine administration.
In some dogs, particularly Boxers and other short nosed breeds,
spontaneous fainting or
syncope may occur, due to sinoatrial block caused by excessive vagal
tone, and an attack
may be precipitated by acepromazine, so a low dose should be used.
Where there is a
history of this type of syncope, or if it is suspected bec
                                
                                Read the complete document
                                
                            

Search alerts related to this product